Hamilton Lane Incorporated logo HLNE - Hamilton Lane Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 3
SELL 1
STRONG
SELL
0
| PRICE TARGET: $144.00 DETAILS
HIGH: $179.00
LOW: $102.00
MEDIAN: $148.00
CONSENSUS: $144.00
UPSIDE: 59.43%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Fair Value Moderate
Trading 19.1% below fair value
Current Price $90.32
Bear Case $78.11 13.5% downside ($78.11 - $90.32) / $90.32 = -13.5% ROTCE 20.0% → 2.33x TBV
Fair Value $111.58 23.5% upside ($111.58 - $90.32) / $90.32 = 23.5% ROTCE 25.0% → 3.39x TBV
Bull Case $145.05 60.6% upside ($145.05 - $90.32) / $90.32 = 60.6% ROTCE 30.0% → 3.79x TBV

Adjust Assumptions

27.2%
10.9%

Key Value Driver

ROTCE (27.2%) vs. cost of equity (10.9%)

Implied Market Multiple 5.48x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $144.00 from 10 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $111.58 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $144.00 (from 10 analysts). Our estimate is 28% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly